The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Pfizer naming Susan Mitchell .

Filed returns
21
match these filters
Matching filed returns per period 0 1 2 3 5 May–Aug 2020: 1 filed returns Jan–Apr 2021: 1 filed returns May–Aug 2021: 1 filed returns Sep–Dec 2021: 2 filed returns Jan–Apr 2022: 1 filed returns May–Aug 2022: 3 filed returns Sep–Dec 2022: 3 filed returns Jan–Apr 2023: 2 filed returns May–Aug 2023: 2 filed returns Sep–Dec 2023: 1 filed returns Jan–Apr 2024: 2 filed returns May–Aug 2024: 1 filed returns Sep–Dec 2024: 1 filed returns 2021 2022 2023 2024
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Sep–Dec 2024 Pfizer Health Access to an antiviral medication for the treatment of COVID-19 (Matters involving public funds) 5 On lobbying.ie
May–Aug 2024 Pfizer EU Affairs EU Pharmaceutical Legislation proposals (Legislation) 14 On lobbying.ie
Jan–Apr 2024 Pfizer EU Affairs EU Pharmaceutical Legislation proposals (Legislation) 9 On lobbying.ie
Jan–Apr 2024 Pfizer Health Ireland's medicine reimbursement system and access to new medicines and vaccines (Matters involving public funds) 14 On lobbying.ie
Sep–Dec 2023 Pfizer Health Ireland's medicine reimbursement system and Budget funding for new medicines (Matters involving public funds) 9 On lobbying.ie
May–Aug 2023 Pfizer EU Affairs EU Pharmaceutical Legislation proposals (Legislation) 5 On lobbying.ie
May–Aug 2023 Pfizer Health Ireland's reimbursement system and funding for new medicines (Public policy or programme) 6 On lobbying.ie
Jan–Apr 2023 Pfizer Health Ireland's pricing and reimbursement system and funding for new medicines (Public policy or programme) 14 On lobbying.ie
Jan–Apr 2023 Pfizer EU Affairs EC HERA contract in relation to Pfizer COVID-19 vaccine (Matters involving public funds) 5 On lobbying.ie
Sep–Dec 2022 Pfizer Health Pfizer anti-viral COVID-19 treatment and COVID-19 cases (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2022 Pfizer EU Affairs EC HERA contract in relation to Pfizer COVID-19 vaccine (Matters involving public funds) 5 On lobbying.ie
Sep–Dec 2022 Pfizer Budgetary matters Budget 2023 (Public policy or programme) 8 On lobbying.ie
May–Aug 2022 Pfizer Budgetary matters Budget 2023 (Public policy or programme) 9 On lobbying.ie
May–Aug 2022 Pfizer Health COVID-19 vaccination programme (Public policy or programme) 4 On lobbying.ie
May–Aug 2022 Pfizer Health Pfizer COVID-19 anti-viral treatment (Public policy or programme) 3 On lobbying.ie
Jan–Apr 2022 Pfizer Health Update on Pfizer COVID 19 antiviral treatment and processes in ensuring availability of the treatment in Ireland (Matters involving public funds) 2 On lobbying.ie
Sep–Dec 2021 Pfizer Health COVID-19 vaccination programme (Public policy or programme) 5 On lobbying.ie
Sep–Dec 2021 Pfizer Health Pfizer has an investigational COVID-19 treatment, a protease inhibitor which subject to clinical trials and regulatory approvals could play a complementary role to vaccination in helping to manage COVID-19 (Matters involving public funds) 5 On lobbying.ie
May–Aug 2021 Pfizer Health Supply of Pfizer COVID-19 vaccine including Ireland volumes; expansion of manufacturing capacity to include Grange Castle site and Pfizer colleague vaccination programme (Public policy or programme) 8 On lobbying.ie
Jan–Apr 2021 Pfizer Health Updates in relation to Pfizer COVID 19 vaccine including global production, Ireland volumes and company colleague vaccination programme (Matters involving public funds) 10 On lobbying.ie
May–Aug 2020 Pfizer Health Provided information about Pfizer's research into a COVID-19 vaccine, meeting sought with MoH/DoH. (Public policy or programme) 29 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 14 66.7%
EU Affairs 5 23.8%
Budgetary matters 2 9.5%